ИНСУЛИНОРЕЗИСТЕНТЛИК ВА ЯЛЛИҒЛАНИШ БИОМАРКЕРЛАРИ ЎТКИР ИШЕМИК ИНСУЛЬТНИНГ КЕЙИНГИ ФУНКЦИОНАЛ ХОЛАТ ПРЕДИКТОРЛАРИ СИФАТИДА
##article.subject##:
ўткир ишемик инсульт, инсулинга резистентлик, яллиғланиш биомаркерлари, TOAST классификацияси, прогноз##article.abstract##
Мақолада ўткир ишемик инсультда инсулинга резистентлик ва яллиғланиш биомаркерларининг прогноздаги ўрни баҳоланган. Тадқиқот натижаларига кўра, биомаркер концентрацияси инсульт подтипларига қараб фарқланади, шунингдек инсулинорезистентлик ва юқори яллиғланиш фаоллиги ёмон функционал ҳолатлар билан боғлиқ.
Библиографические ссылки
Abdurakhmonova K.B, Rakhimbaeva G.S. ICAM-1 and C-reactive protein as biomarkers of 3-month outcome in acute ischaemic stroke. BMJ Neurol Open. 2023;5(1):e000516. doi:10.1136/bmjno-2023-000516.
Jing J, Pan Y, Zhao X, Zheng H, Jia Q, Li H, et al. Insulin resistance and prognosis of nondiabetic patients with ischemic stroke: the ACROSS-China study. Stroke. 2017;48(4):887-93. doi:10.1161/STROKEAHA.116.015613.
Ago T, Kitazono T, Ooboshi H, Kamouchi M. Insulin resistance and clinical outcomes after acute ischemic stroke. Neurology. 2018;90(1):e43-50. doi:10.1212/WNL.0000000000004790.
Chang Y, Kim J, Lee JS, Cho H, Park JH, Ahn SH, et al. Insulin resistance is associated with poor functional outcome after acute ischemic stroke in non-diabetic patients. Sci Rep. 2021;11:1229. doi:10.1038/s41598-020-80315-z.
Zhou Y, Li X, Zhang J, Wu H, Chen H, Wang L, et al. Adipose tissue-specific insulin resistance and prognosis of ischemic stroke: a prospective cohort study. Diabetol Metab Syndr. 2023;15(1):21. doi:10.1186/s13098-023-01235-2.
Sun Y, Li Z, Liu Y, Zhang H, Wang Y, Chen X, et al. Effect of insulin resistance on prognosis of intravenous thrombolysis in patients with acute ischemic stroke. Front Neurol. 2025;16:1504891. doi:10.3389/fneur.2025.1504891.
Jin A, Xu Y, Wang Y, Zhang J, Zhao X, Pan Y, et al. Mediation of systemic inflammation on insulin resistance in nondiabetic patients with ischemic stroke. Stroke. 2023;54(3):891-9. doi:10.1161/STROKEAHA.122.039542.
Wang L, Zhang H, Wang Y, Xu J, Liu X. Serum ICAM-1 as a predictor of prognosis in patients with acute ischemic stroke. Front Neurol. 2021;12:666510. doi:10.3389/fneur.2021.666510.
Wang M, Liu X, Xu Y, Chen J, Zhao Y, Li H, et al. Association between soluble intercellular adhesion molecule-1 levels on admission and poor outcomes after acute ischemic stroke. Stroke. 2023;54(9):2591-600. doi:10.1161/STROKEAHA.123.042466.
Ding PF, Chen Y, Xu W, Zhou Y, Liu J. Insulin resistance in ischemic stroke: mechanisms and therapeutic implications. Front Endocrinol. 2022;13:1092431. doi:10.3389/fendo.2022.1092431.
Asedi T, Yan H, Liu S, Qian L, Chen W, Chen X, et al. Impact of insulin resistance on clinical outcomes after acute ischemic stroke. Neurology. 2025;94(12):e1234-42. doi:10.1212/WNL.0000000000208964.
Huang Y, Wang Z, Huang ZX, Liu Z. Biomarkers and the outcomes of ischemic stroke. Front Mol Neurosci. 2023;16:1171101. doi:10.3389/fnmol.2023.1171101.
